Testimonials
This is the only product I have ever taken that I truly believe in. It has been like a miracle. I will continue to take the product.
Tony G. (Hall of Fame, Major League Baseball Player)
Poway, CA
I am 78 years old and now plan to ski, hunt, and scuba dive again - my favorite sports. Thanks Celadrin for giving me my life back again!
Walter W.
Largo, FL
Thank you very much for developing this formulation. I hope that I never have to be without it, it's that GOOD!
Dr. Thomas R. PhD
La Jolla, CA
Nothing has made a difference like Celadrin has. My mobility has increased almost 100%.
Chuck G.
Westlake, OR
Quick Links
Publications
May 2005
A Cetylated Fatty Acid Topical Cream Reduces Pain and Improves Functional Performance in Patients with Arthritis.
—Published in the Journal of Strength & Conditioning
Apr 2004
The effects of a cetylated fatty acid topical cream on functional mobility and quality of life of patients with osteoarthritis.
—Published in the Journal of Rheumatology
Feb 2005
Effects of Treatment With a Cetylated Fatty Acid Topical Cream on Static Postural Stability and Plantar Pressure Distribution in Patients With Knee Osteoarthritis.
—Published in the Journal of Strength & Conditioning
Apr 1, 2003
Digestion and metabolism of cetylated fatty acids in rats.
Oct 31, 2002
Distribution of Cetylated Fatty Acids in Rats after Oral or Topical Administration.
Oct 1, 2002
Digestion and Metabolism of Cetylated Fatty Acids in Rats.
Sep 17, 2002
A Preliminary Study for the use of Celadrin for the Treatment of Psoriasis.
Aug 2002
Cetylated Fatty Acids Improve Knee Function in Patients with Osteoarthritis.
—Published in the Journal of Rheumatology
Aug 29, 2001
Evaluation of a Topical Cream containing Cetylated Fatty Acids.
2001
The Effect of a Cetylated Fatty Acid (CFA) for Improving Quality of Life in Canines.
2001
A fatty acid ester (CMC) improves quality of life outcomes in osteoarthritis (OA) patients.
Scientific Presentations
2007
The effects of cetylated fatty acid cream on pain, range of motion and quality of life of patients with osteoarthritis. Kraemer WJ, Ratamess NA, Anderson JA, Tiberio DP, Joyce ME, Messinger BN, French DN, Sharman MJ, Rubin MR, Gomez AL, Volek JS, Hesslink R Jr.
2003
The effects of a cetylated fatty acid cream on functional mobility and performance in patients with osteoarthritis. Ratamess NA, Kraemer WJ, Anderson JA, Tiberio DP, Joyce ME, Messinger BN, French DN, Sharman MJ, Rubin MR, Gomez AL, Volek JS, Hesslink R Jr.
2003
Absorption and metabolism of a cetylated fatty acid. Islam A, Gallaher C.M., and Gallaher D.D.
2002
Digestion and metabolism of cetylated fatty acids in rats. Gallaher D.D., Gallaher C.M., Hesslink R. Jr.
2002
The effects of a cetylated fatty acid complex on canine osteoarthritis. Hesslink R.L., and Sprouse S.
2001
A fatty acid ester (CMC) improves quality of life outcomes in osteoarthritis (OA) patients. Barathur R.R., Bookout J.B., Sreevatsan S, Freedland E.S. and Hesslink Jr., R.L.
Technical Reports
2002
Bacterial reverse mutation Ames test screening MDS Pharma, Les Oncins, France.
2002
Evaluation of topical cetylated fatty acid application to psoriasis patients Dermatologist Medical Group of North County, Inc.
2001
The acute toxicology of oral cetylated fatty acid gavage CD-1 mouse model Perry Scientific, Inc.
2000
Evaluation of a topical cream containing cetylated fatty acids using hairless mouse model Perry Scientific, Inc., Study No. 00-1076
family of products.